Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 387

1.

Not All Cellular Rejections are the Same: Differences in Early and Late Hepatic Allograft Rejection.

Jadlowiec CC, Morgan PE, Avinash NK, Hathcock MA, Kremers WK, Heimbach JK, Wiesner RH, Taner T.

Liver Transpl. 2019 Jan 7. doi: 10.1002/lt.25411. [Epub ahead of print]

PMID:
30615251
2.

Simultaneous Liver Kidney Transplantation.

Singal AK, Ong S, Satpathy S, Kamath PS, Wiesner RH.

Transpl Int. 2018 Dec 10. doi: 10.1111/tri.13388. [Epub ahead of print] Review.

PMID:
30548094
3.

Factors Influencing Surveillance for Hepatocellular Carcinoma in Patients with Liver Cirrhosis.

Ahmed Mohammed HA, Yang JD, Giama NH, Choi J, Ali HM, Mara KC, Harmsen WS, Wiesner RH, Leise MD, Therneau TM, Roberts LR.

Liver Cancer. 2017 Feb;6(2):126-136. doi: 10.1159/000450833. Epub 2016 Dec 17.

4.

Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.

Mouchli MA, Singh S, Loftus EV Jr, Boardman L, Talwalkar J, Rosen CB, Heimbach JK, Wiesner RH, Hasan B, Poterucha JJ, Kymberly WD.

Transplantation. 2017 Aug;101(8):1859-1866. doi: 10.1097/TP.0000000000001725.

5.

Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.

Yang JD, Larson JJ, Watt KD, Allen AM, Wiesner RH, Gores GJ, Roberts LR, Heimbach JA, Leise MD.

Clin Gastroenterol Hepatol. 2017 May;15(5):767-775.e3. doi: 10.1016/j.cgh.2016.11.034. Epub 2016 Dec 21.

6.

Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease.

Kittanamongkolchai W, El-Zoghby ZM, Eileen Hay J, Wiesner RH, Kamath PS, LaRusso NF, Watt KD, Cramer CH, Leung N.

Hepatol Int. 2017 Jul;11(4):384-389. doi: 10.1007/s12072-016-9775-9. Epub 2016 Dec 8.

PMID:
27933591
7.

Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation.

Singal AK, Fang X, Kaif M, Hasanin M, Mcguire BM, Kuo YF, Wiesner RH.

Transpl Int. 2017 May;30(5):454-462. doi: 10.1111/tri.12877. Epub 2016 Nov 14.

8.

Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.

Lynn AM, Singh S, Congly SE, Khemani D, Johnson DH, Wiesner RH, Kamath PS, Andrews JC, Leise MD.

Liver Transpl. 2016 Jun;22(6):723-31. doi: 10.1002/lt.24440.

9.

Acute Liver Failure Prognostic Scores: Is Good Enough Good Enough?

Kamath PS, Heimbach J, Wiesner RH.

Clin Gastroenterol Hepatol. 2016 Apr;14(4):621-3. doi: 10.1016/j.cgh.2015.12.025. Epub 2015 Dec 24. No abstract available.

PMID:
26724727
10.

In a rapidly changing world, can we truly predict the impact of liver graft quality 15 years from now?

Wiesner RH.

Liver Transpl. 2015 Aug;21(8):1011-2. doi: 10.1002/lt.24203. No abstract available.

11.

Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.

Dhanasekaran R, Sanchez W, Mounajjed T, Wiesner RH, Watt KD, Charlton MR.

Liver Int. 2015 Nov;35(11):2433-41. doi: 10.1111/liv.12890. Epub 2015 Jul 1.

PMID:
26058570
12.

Outcomes of liver transplantation alone after listing for simultaneous kidney: comparison to simultaneous liver kidney transplantation.

Hmoud B, Kuo YF, Wiesner RH, Singal AK.

Transplantation. 2015 Apr;99(4):823-8. doi: 10.1097/TP.0000000000000438.

PMID:
25250648
13.

Evolving trends in liver transplantation: listing and liver donor allocation.

Wiesner RH.

Clin Liver Dis. 2014 Aug;18(3):519-27. doi: 10.1016/j.cld.2014.05.014. Review.

PMID:
25017073
14.

Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology.

Singal AK, Salameh H, Kuo YF, Wiesner RH.

Transplantation. 2014 Jul 27;98(2):216-21. doi: 10.1097/TP.0000000000000048.

PMID:
24621538
15.

De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.

Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E, Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM.

Am J Transplant. 2014 Feb;14(2):356-66. doi: 10.1111/ajt.12543. Epub 2014 Jan 23.

16.

Transcatheter aortic valve replacement in patients with cirrhosis.

Greason KL, Mathew V, Wiesner RH, Suri RM, Rihal CS.

J Card Surg. 2013 Sep;28(5):492-5. doi: 10.1111/jocs.12177. Epub 2013 Jul 30.

PMID:
23899420
17.

Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward.

Krowka MJ, Wiesner RH, Heimbach JK.

J Hepatol. 2013 Aug;59(2):367-74. doi: 10.1016/j.jhep.2013.03.026. Epub 2013 Apr 1. Review.

18.

Moving toward evidence-based liver allocation in patients with primary sclerosing cholangitis.

Wiesner RH.

Liver Transpl. 2013 Mar;19(3):241-2. doi: 10.1002/lt.23601. No abstract available.

19.

Evolving frequency and outcomes of liver transplantation based on etiology of liver disease.

Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH.

Transplantation. 2013 Mar 15;95(5):755-60. doi: 10.1097/TP.0b013e31827afb3a.

PMID:
23370710
20.

Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease.

Heimbach JK, Watt KD, Poterucha JJ, Ziller NF, Cecco SD, Charlton MR, Hay JE, Wiesner RH, Sanchez W, Rosen CB, Swain JM.

Am J Transplant. 2013 Feb;13(2):363-8. doi: 10.1111/j.1600-6143.2012.04318.x. Epub 2012 Nov 8.

Supplemental Content

Loading ...
Support Center